Multiple Myeloma-Associated Light Chain Amyloidosis and a Proposed Approach to Monoclonal Immunoglobulin-Associated Renal Disease
Open Access
- 11 September 2020
- journal article
- case report
- Published by S. Karger AG in Case Reports in Nephrology and Dialysis
- Vol. 10 (3) , 95-103
Abstract
Many challenges remain in diagnosing monoclonal immunoglobulin-associated renal disease, despite widespread application of immunofluorescence (IF) and immunohistochemistry. Here, we report a newly diagnosed case of multiple myeloma with clinical suspicion of renal amyloidosis, which had negative IF staining for kappa and lambda light chains in the glomeruli. Although laser microdissection and mass spectrometry-based proteomic analysis have emerged as important tools for amyloid typing in the literature, such facilities are still not widely available in Asia. We propose that a clinicopathological algorithm for the evaluation of organized monoclonal renal deposits, together with a combined nephrological-haematological approach, will still be adequate to generate an unequivocal diagnosis in the majority of cases.Keywords
This publication has 14 references indexed in Scilit:
- DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary GlomerulonephritisKidney International Reports, 2018
- Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin depositsKidney International, 2015
- Progression of Monoclonal Gammopathy with Undetermined Significance to Multiple Myeloma Diagnosed by Kidney Biopsy: A Case ReportCase Reports in Nephrology and Dialysis, 2015
- Diagnosis of monoclonal gammopathy of renal significanceKidney International, 2015
- Amyloid nephropathyClinical Kidney Journal, 2014
- Renal AmyloidosisClinical Journal of the American Society of Nephrology, 2013
- Laser microdissection and mass spectrometry–based proteomics aids the diagnosis and typing of renal amyloidosisKidney International, 2012
- Classification of amyloidosis by laser microdissection and mass spectrometry–based proteomic analysis in clinical biopsy specimensBlood, 2009
- Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain AmyloidosisJournal of the American Society of Nephrology, 2009
- Myeloma – new approaches to combined nephrological–haematological managementNephrology Dialysis Transplantation, 2006